ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors.

Julien Hadoux et al.PubMed ↗Publisher ↗

No numbers read from the abstract.